1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Dapgliflozin + metformin
Trade Name:
Xigduo
Manufacturer/Distributor:
AstraZeneca Canada
Classification:
Sodium-glucose contransporter 2 (SGLT2) inhibitor plus metformin
ATC Class:
A10BD15 - combination of oral blood glucose lowering agents
Status:
active
Notice of Compliance (yyyy/mm/dd):
2015/12/10
Date Marketed in Canada (yyyy/mm/dd):
2016/02/08
Presentation:
Tablet: 5 mg dapligliflozin + 850 mg metformin. DIN: 02449935
Tablet: 5 mg dapligliflozin + 1000 mg metformin. DIN: 02449943
Comments:
For use as an adjunct to diet and exercise in adults with type 2 diabetes mellitus who are already being treated with
dapagliflozin and metformin as separate tablets and achieving glycemic control.
Back to:
Drug Product Listings 
